Impact of prenatal corticosteroid therapy on sickle cell disease in pregnant women.

Date publication

mai 2023

Journal

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics

Auteurs

Membres identifiés du Cancéropôle Est :
Pr GRAESSLIN Olivier

Tous les auteurs :
Wang F, Mandelbrot L, Affo L, Galacteros F, Bounan S, Fernandez H, Fichez A, Cannas G, Driessen M, Debarge V, Loko G, Gnofam M, Makowski C, Graesslin O, Haddad B, Sibiude J,

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/37158403

Résumé

To evaluate safety of prenatal corticosteroids in pregnancies of women with sickle cell disease.

Mots clés

pregnancy, prenatal corticosteroids, preterm birth, sickle cell disease, vaso-occlusive crisis

Référence

Int J Gynaecol Obstet. 2023 05 9;: